This information will allow you to anticipate prescribing changes and adjust your stock levels accordingly. When a patient’s medication is switched they may be anxious about the change. This could be a great opportunity to invite them for a NMS consultation if the switch involves a new medication, they may be eligible. The NMS specification regarding eligibility of patients for NMS after a formulation change states:-
‘’It is not generally appropriate for NMS to be provided where there has been a formulation change. The rationale for this is that a change from one solid dosage form to another is unlikely to present major clinical issues for a patient and hence provision of the NMS in such circumstances would not provide value to the NHS. However there may be circumstances, where in the professional opinion of the pharmacist, they believe the patient would benefit from the provision of the NMS where they are moving from one formulation of a medicine to another. In this case the NMS can be provided and pharmacists should document their rationale for making such a professional decision’’.
Please observe the instructions in the following 1 minute video showing how to open the childproof blister packaging: https://www.oxypro-info.com/patient/#support-materials, the following PDF of the patient leaflet can be printed off to explain to the patient: PIL- Oxypro15954
Simple switches document for all Humber CCG areas:
Please Note: Following feedback from contractors, NECS have now confirmed that the proposed switch from Diltiazem to Retalzem will not be implemented.
North school of pharmacy and medicines optimisation:
North school of pharmacy and medicines optimisation are responsible for ensuring the delivery of professional and vocational training. Supporting the workforce in understanding the safe handling of medicines and how we can ensure good medicines optimisation skills are spread across health and social care, is a key priority. Visit their website.